Literature DB >> 6858773

Surgical therapy for blepharospasm.

A F Battista.   

Abstract

Over the past 3 1/2 years, 28 patients with blepharospasm have undergone, bilaterally, staged percutaneous thermolytic fractional destruction of branches of the facial nerve. This series consisted of 20 women and eight men ranging in age from 40 to 79 years, with symptoms for from 1 to over 10 years. At the time of follow-up, 12 patients had undergone one operation, 12 had had two operations, and four had had three to five operations. Sixteen of the 28 patients obtained excellent to good relief of symptoms for 1 to 3 1/2 years. The procedures performed using local anesthesia and intravenous analgesia allow the immediate recognition of any facial muscle weakness or asymmetry. The findings indicate that this procedure, in many patients with minimal complications, can significantly relieve the incapacitating symptoms of blepharospasm.

Entities:  

Mesh:

Year:  1983        PMID: 6858773

Source DB:  PubMed          Journal:  Adv Neurol        ISSN: 0091-3952


  2 in total

1.  Clinical outcomes of individualized botulinum neurotoxin type A injection techniques in patients with essential blepharospasm.

Authors:  Youngje Sung; Sang Min Nam; Helen Lew
Journal:  Korean J Ophthalmol       Date:  2015-03-17

2.  SURGICAL ASPECT OF BLEPHAROSPASM TREATMENT: A CASE REPORT.

Authors:  Kristijan Dinjar; Vedran Zubčić; Andrijana Kopić; Vlatko Kopić; Bruno Popić; Dubravka Holik
Journal:  Acta Clin Croat       Date:  2020-06       Impact factor: 0.780

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.